Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Other Non-Current Liabilities (2019 - 2025)

Revolution Medicines has reported Other Non-Current Liabilities over the past 7 years, most recently at $18.5 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $18.5 million for Q4 2025, up 2668.06% from a year ago — trailing twelve months through Dec 2025 was $18.5 million (up 2668.06% YoY), and the annual figure for FY2025 was $18.5 million, up 2668.06%.
  • Other Non-Current Liabilities for Q4 2025 was $18.5 million at Revolution Medicines, up from $5.9 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for RVMD hit a ceiling of $18.5 million in Q4 2025 and a floor of $219000.0 in Q2 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $1.4 million (2021), compared with a mean of $2.6 million.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 63.98% in 2022 and later skyrocketed 2668.06% in 2025.
  • Revolution Medicines' Other Non-Current Liabilities stood at $634000.0 in 2021, then tumbled by 52.52% to $301000.0 in 2022, then soared by 384.39% to $1.5 million in 2023, then tumbled by 54.05% to $670000.0 in 2024, then skyrocketed by 2668.06% to $18.5 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $18.5 million (Q4 2025), $5.9 million (Q3 2025), and $5.3 million (Q2 2025) per Business Quant data.